Teclison

Teclison

Biotechnology, 26 Park St, Montclair, New Jersey, 07042, United States, 1-10 Employees

teclison.com

  • LinkedIn

Who is TECLISON

Teclison was founded with the vision of assembling leading scientists, advisors, and other leaders with significant pharmaceutical expertise to develop groundbreaking therapies for cancer...

Read More

map
  • 26 Park St, Montclair, New Jersey, 07042, United States Headquarters: 26 Park St, Montclair, New Jersey, 07042, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from TECLISON

Teclison Org Chart and Mapping

Employees

Ray Lee

Founder and Chief Medical Office

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Teclison

Answer: Teclison's headquarters are located at 26 Park St, Montclair, New Jersey, 07042, United States

Answer: Teclison's official website is https://teclison.com

Answer: Teclison's revenue is $1 Million to $5 Million

Answer: Teclison's SIC: 8731

Answer: Teclison has 1-10 employees

Answer: Teclison is in Biotechnology

Answer: Teclison contact info: Phone number: Website: https://teclison.com

Answer: Teclison was founded with the vision of assembling leading scientists, advisors, and other leaders with significant pharmaceutical expertise to develop groundbreaking therapies for cancer. The company specializes in the development of innovative cancer medicines which induce tumor necrosis and enhance anti-tumor immunity for long-term cancer remission. The companys drug is designed to treat any solid tumor with a predilection for liver metastasis, including hepatocellular carcinoma and metastatic colorectal cancer first, and expanding to other solid tumors with liver metastasis. Teclisons novel approach is a first-in-class hypoxia-activating agent which achieves long-term remission in hard-to-treat cancer cell, cancer stem cells and tumor-promoting macrophage targets by creating high local concentration of its compound and producing profound hypoxia exclusively within the tumor

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access